Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT01076374 |
Date of registration:
|
24/02/2010 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY
|
Scientific title:
|
Medtronic Adapta/Versa/Sensia Long Term Reliability Study |
Date of first enrolment:
|
July 2008 |
Target sample size:
|
2927 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01076374 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Australia
|
Austria
|
Belgium
|
Canada
|
Denmark
|
Former Serbia and Montenegro
|
France
|
Germany
|
Italy
|
Netherlands
|
Serbia
|
Spain
|
Sweden
|
Switzerland
|
United States
| |
Contacts
|
Name:
|
nEw3 PAS Clinical Trial Leader |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Medtronic |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Subjects or appropriate legal guardians provide written informed consent and/or
authorization for access to and use of health information, as required by an
institution's IRB/MEC/REB.
AND one of the following must also apply:
- Subjects indicated for implant or within six months post-implant of a Medtronic
market-released lead connected to a Medtronic Adapta®, Sensia™, or Versa™ IPG. The
Medtronic lead must be used for pacing, sensing or defibrillation application.
- Subjects who participated in a qualifying study (IDE) of a Medtronic cardiac therapy
product and: 1) have a Medtronic Adapta®, Sensia™, or Versa™ IPG 2)product is
market-released 3) complete implant and follow-up data, including product-related
adverse events are available and 4) subject of appropriate legal guardian authorizes
release of subject study data to SLS
- Subjects implanted with a Medtronic Adapta®, Sensia™, or Versa™ IPG and Medtronic
CapSure Epi Leads (model 4965 and 4968) at a minimum of three pre-selected sites to
retrospectively collect data for post approval requirements.
Exclusion Criteria:
- Subjects who are, or will be inaccessible for follow-up at a SLS center
- Subjects with exclusion criteria required by local law (EMEA only)
- Subjects receiving an implant of a Medtronic device at a non-participating center and
the implant data and current status cannot be confirmed within 30 days after implant
- Subjects implanted with a Medtronic device whose predetermined enrollment limit for
that specific product has been exceeded
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Bradycardia
|
Arrhythmia
|
Primary Outcome(s)
|
Rate of device malfunctions
[Time Frame: 5 years]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|